MRPL39
Basic information
Region (hg38): 21:25585656-25607517
Links
Phenotypes
GenCC
Source:
- mitochondrial disease (Moderate), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Combined oxidative phosphorylation deficiency 59 | AR | Cardiovascular | The condition has been described as including hypertrophic cardiomyopathy, and awareness may allow early recognition and management | Biochemical; Cardiovascular; Neurologic | 37133451 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MRPL39 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 17 | 18 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 3 | |||||
Total | 0 | 3 | 18 | 0 | 1 |
Variants in MRPL39
This is a list of pathogenic ClinVar variants found in the MRPL39 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
21-25587768-G-C | not specified | Uncertain significance (Apr 11, 2023) | ||
21-25592807-C-T | Leigh syndrome • Combined oxidative phosphorylation deficiency 59 | Pathogenic/Likely pathogenic (Dec 05, 2023) | ||
21-25592837-C-A | Mitochondrial disease • Combined oxidative phosphorylation deficiency 59 | Likely pathogenic (Feb 04, 2021) | ||
21-25592891-G-A | not specified | Uncertain significance (Jan 26, 2022) | ||
21-25592951-A-G | not specified | Uncertain significance (Jun 13, 2023) | ||
21-25592962-T-C | not specified | Uncertain significance (May 16, 2024) | ||
21-25593918-G-C | not specified | Uncertain significance (Nov 17, 2022) | ||
21-25593941-A-G | not specified | Uncertain significance (Oct 25, 2023) | ||
21-25597305-C-A | not specified | Uncertain significance (Aug 04, 2023) | ||
21-25597366-C-T | not specified | Uncertain significance (Aug 13, 2021) | ||
21-25597371-T-C | not specified | Uncertain significance (Jun 11, 2021) | ||
21-25597380-G-A | not specified | Uncertain significance (Mar 27, 2023) | ||
21-25598338-C-T | Leigh syndrome • Combined oxidative phosphorylation deficiency 59 | Likely pathogenic (Jun 24, 2022) | ||
21-25599832-C-A | not specified | Uncertain significance (Jun 09, 2022) | ||
21-25599860-GA-G | Leigh syndrome • Combined oxidative phosphorylation deficiency 59 | Likely pathogenic (Jun 24, 2022) | ||
21-25601389-C-T | not specified | Uncertain significance (Jan 18, 2022) | ||
21-25601445-A-G | not specified | Uncertain significance (May 17, 2023) | ||
21-25601452-A-T | not specified | Uncertain significance (Feb 06, 2024) | ||
21-25603803-A-G | not specified | Uncertain significance (Jan 26, 2022) | ||
21-25603928-G-C | not specified | Uncertain significance (May 18, 2022) | ||
21-25606461-T-A | not specified | Uncertain significance (Feb 28, 2024) | ||
21-25606509-C-T | not specified | Uncertain significance (Apr 03, 2023) | ||
21-25606523-T-C | not specified | Uncertain significance (Feb 09, 2023) | ||
21-25606638-A-A | Benign (Dec 31, 2019) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
MRPL39 | protein_coding | protein_coding | ENST00000307301 | 11 | 21862 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00000431 | 0.959 | 125671 | 0 | 77 | 125748 | 0.000306 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.373 | 206 | 191 | 1.08 | 0.00000979 | 2297 |
Missense in Polyphen | 50 | 53.466 | 0.93518 | 711 | ||
Synonymous | -0.771 | 74 | 66.0 | 1.12 | 0.00000348 | 647 |
Loss of Function | 1.90 | 12 | 21.5 | 0.557 | 0.00000118 | 263 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000631 | 0.000623 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000397 | 0.000396 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.000366 | 0.000359 |
Other | 0.000164 | 0.000163 |
dbNSFP
Source:
- Pathway
- Mitochondrial translation initiation;Translation;Metabolism of proteins;Mitochondrial translation elongation;Mitochondrial translation termination;Mitochondrial translation
(Consensus)
Recessive Scores
- pRec
- 0.114
Intolerance Scores
- loftool
- 0.874
- rvis_EVS
- 0.22
- rvis_percentile_EVS
- 68.44
Haploinsufficiency Scores
- pHI
- 0.149
- hipred
- N
- hipred_score
- 0.196
- ghis
- 0.563
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.587
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Mrpl39
- Phenotype
Gene ontology
- Biological process
- mitochondrial translational elongation;mitochondrial translational termination
- Cellular component
- mitochondrion;mitochondrial inner membrane;mitochondrial ribosome;mitochondrial large ribosomal subunit
- Molecular function
- nucleotide binding;RNA binding